Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis-Reference-Cited by-同舟云学术

Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis

Published:2011-05-04 Issue:4 Volume:18 Page:605-611
ISSN:1071-3581
Container-title:Journal of Nuclear Cardiology
language:en
Short-container-title:J. Nucl. Cardiol.

Author:

Palani Gurunanthan,Husain Zehra,Salinas Rafael Cabrera,Karthikeyan Vanji,Karthikeyan Aarthee S.,Ananthasubramaniam Karthik

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s12350-011-9378-8.pdf

Reference23 articles.

1. Shryock JC, Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology. Am J Cardiol 1997;79:2-10.

2. Fredholm BB, et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001;53:527-52.

3. Gordi T, Blackburn B, Lieu H. Regadenoson pharmacokinetics and tolerability in subjects with impaired renal function. J Clin Pharmacol 2007;47:825-33.

4. Cerqueira MD. The future of pharmacologic stress: Selective A2A adenosine receptor agonists. Am J Cardiol 2004;94:33D-40D. (discussion 40D-42D).

5. Garnock-Jones KP, Curran MP. Regadenoson. Am J Cardiovasc Drugs 2010;10:65-71.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological strategies for mitigating anti-TNF biologic immunogenicity in rheumatoid arthritis patients;Current Opinion in Pharmacology;2023-02

2. Role of Cardiac A2A Receptors Under Normal and Pathophysiological Conditions;Frontiers in Pharmacology;2021-01-26

3. The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date;Journal of Nuclear Cardiology;2020-07-06

4. Asystole following Regadenoson administration: Review of literature, risk factors and management;Journal of Nuclear Cardiology;2020-05-27

5. Evidence for Arrhythmogenic Effects of A2A-Adenosine Receptors;Frontiers in Pharmacology;2019-09-18